29.9 C
Vientiane
Thursday, August 21, 2025
spot_img
Home Blog Page 324

Rwazi Raises $12M to Replace Every Gut Call with an AI Copilot

In a world where delays cost millions, this AI copilot shows teams what’s changing, what to do, and what happens next.

LOS ANGELES, July 16, 2025 /PRNewswire/ — Rwazi has raised $12 million in Series A funding to replace every gut call with an AI copilot. The round will accelerate development of its simulation engine and decision copilot — giving teams real-time visibility into what’s changing, what to do next, and what outcome to expect.

Rwazi co-founders Joseph Rutakangwa (left) and Eric Sewankambo (right), following the company’s $12M Series A to accelerate its AI copilot.
Rwazi co-founders Joseph Rutakangwa (left) and Eric Sewankambo (right), following the company’s $12M Series A to accelerate its AI copilot.

“For decades, decisions have been driven by instinct. But gut calls are expensive — and in today’s market, they’re dangerous,” said Joseph Rutakangwa, Co-Founder & CEO. “This raise lets us put a real-time AI copilot in the hands of every decision-maker — so teams can move faster, smarter, and with total clarity.”

Unlike most AI systems built on scraped content, passive signals, or modeled behavior, Rwazi captures real-time consumer activity — shared directly and voluntarily at a massive scale. That precision powers a new kind of intelligence system: one that helps teams detect shifts early, simulate outcomes, and act with speed and confidence.

The system sharpens constantly — learning from patterns to refine how it understands markets, predicts shifts, and guides action. Rwazi already analyzes billions of behavioral signals across demographics, markets, and products. The result: decision-making that’s not just faster, but surgically precise. Teams move with clarity, leaders with conviction — and businesses finally operate at the speed of change.

Already trusted by Fortune 100 teams, Rwazi helps enterprises:

  • Grow market share by spotting opportunities before competitors
  • Reduce customer acquisition costs by understanding what resonates, where, and why
  • Increase customer lifetime value by aligning product, pricing, and channel decisions with real-time demand

The funding will be used to deepen Rwazi’s simulation capabilities, expand its global data infrastructure, and enhance its AI copilot’s ability to contextualize and recommend next best moves across functions. As economic volatility rises, companies are realizing that delayed reporting is no longer enough.

“Gut instinct might’ve worked when things moved slowly. But today, the teams that win are the ones with systems that see early and act fast,” Rutakangwa added. “That’s exactly what we’re building.”

Learn more at Rwazi .

Rwazi is an AI company delivering decision intelligence that helps enterprise teams drive growth, cut waste, and act with clarity. Fortune 100 companies use Rwazi to support strategic decisions across marketing, product, and operations.

 

NYSE Content Advisory: Pre-Market update + Wall Street readies for big bank earnings

NEW YORK, July 16, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

 

NYSE Content Advisory: Pre-Market update + Wall Street readies for big bank earnings

Caroline Woods delivers the pre-market update on July 16th

  • Stocks are pointing to a weaker open Wednesday morning as investors digest a second batch of big bank earnings and await another read on inflation.
  • NYSE-listed Bank of America, Goldman Sachs, and Morgan Stanley headline this morning’s earnings activity. This follows results on Tuesday from NYSE-listed J.P. Morgan Chase, Wells Fargo and Citigroup.
  • Wall Street is tracking new inflation data. This comes after the Bureau of Labor Statistics said Tuesday that consumer prices rose in-line with economists’ expectations in June, increasing by 2.7% year-over-year.

Opening Bell
Colony Bankcorp (NYSE: CBAN) celebrates its 50th anniversary and listing transfer

Closing Bell
National Grid (NYSE: NGG) commemorates 25 years listing on the NYSE

Click here to download the NYSE TV App

Samyang Corporation Unveils ‘AI-Based Standardized Sugar Reduction Solution’ at US Food Technology Expo

– Participated in “IFT 2025,” the International Food Technology Expo held in Chicago, United States, from July 14 to 16

– Introduced “3S Solution,” an AI-based standardized sugar reduction solution utilizing specialty ingredients

– Offered tasting samples featuring the latest food solutions and specialty ingredients to enhance visitor understanding

SEOUL, South Korea, July 16, 2025 /PRNewswire/ — Samyang Corporation (CEO Nak-hyun Choi) announced that it participated in the International Food Technology Expo (IFT 2025) held in Chicago, United States, from July 14 to 16.

Samyang Corporation’s promotional booth at IFT 2025
Samyang Corporation’s promotional booth at IFT 2025

The event is hosted annually by the Institute of Food Technologists (IFT) and is the world’s largest exhibition in the field of food technology, attracting over 1,000 companies from around 100 countries. Samyang Corporation participated in the expo to showcase its latest food solutions and products while gaining insights into industry trends.

At this year’s event, Samyang Corporation presented its AI-based standardized sugar reduction solution, the “3S (Smart, Simple, and Successful) Sugar Reduction Solution,” for the first time. The company also offered two types of cereal bars with different textures as tasting samples developed using this solution.

The 3S solution allows customers to input desired sugar reduction levels, ingredient costs, and key factors by product category. The AI then analyzes the data to propose the optimal solution utilizing Samyang Corporation’s specialty ingredients: the alternative sweetener “Allulose” and the water-soluble dietary fiber “resistant maltodextrin.”

Through the 3S solution, Samyang Corporation has significantly shortened product development time while gaining the ability to respond quickly and flexibly to the needs of its customers. The company plans to further advance its AI system to enhance the precision of its sugar reduction solutions and expand its application to a wider range of food categories, including ice cream, sauces, baked goods, and confectionery.

In addition to the 3S solution, Samyang Corporation also showcased the excellence of its specialty ingredients by offering tasting samples such as low-calorie caramel and barbecue sauce made with allulose, as well as gummies and kombucha with enhanced dietary fiber content using resistant maltodextrin.

Allulose is an alternative sweetener that provides about 70% of the sweetness of sugar but with almost zero calories. Samyang Corporation developed liquid allulose in 2016 using its proprietary enzyme technology and has been supplying it both domestically and internationally under the brand name “Nexweet” since 2021.

Resistant maltodextrin is a water-soluble dietary fiber recognized as a health functional food ingredient that may help support healthy bowel movements, suppress after-meal blood sugar spikes, and improve blood triglyceride levels. Samyang Corporation believes this ingredient can create a synergy when combined with allulose, and currently produces both liquid and powder forms of resistant maltodextrin under the brand name “Fiberest.”

Nak-hyun Choi, CEO of Samyang Corporation, stated, “The 3S Solution was designed to provide rapid and accurate recommendations based on the vast research and solution database that Samyang has built over the years. We will continue to enhance the system to improve both the completeness and applicability of our solutions.” He added, “We will also actively leverage this solution to expand our market presence in the United States, where low-sugar and low-calorie products are gaining popularity.”

Meanwhile, Samyang Corporation also plans to promote the excellence and technological strength of its specialty ingredients at upcoming food expos in the second half of this year, including “Health Ingredients (HI) Japan 2025″ and “Supply Side West (SSW) 2025,” which will be held in Japan and the US, respectively.

SC Asset Announces Global Launch Roadshow for “REFERENCE SATHORN – WONGWIANYAI” in Hong Kong, Singapore, and Taipei This July

SINGAPORE and HONG KONG and TAIPEI, July 16, 2025 /PRNewswire/ — SC Asset, one of Thailand’s leading real estate developers, is proud to announce the Global Launch Roadshow for its flagship river view condominium project, REFERENCE SATHORN – WONGWIANYAI, this July 18–19. The international showcase will be held in three strategic locations across Asia: Hong Kong, Singapore, and Taipei, reflecting the company’s commitment to meeting growing regional demand for premium Bangkok real estate.

The event schedule includes:

  • Hong Kong: Park Lane Hotel, Causeway Bay, 19 July 2025
  • Singapore: Marriott Tang Plaza Hotel, 19 July 2025
  • Taipei: Guo Chang Building (near Taipei Arena), 18–19 July 2025

Located just 130 meters from BTS Wongwian Yai Station, REFERENCE SATHORN – WONGWIANYAI places you effortlessly within reach of Sathorn CBD and Siam—two of Bangkok’s most dynamic business and lifestyle districts. Just a few stops away lies ICONSIAM, the city’s premier world-class shopping and entertainment destination.

This striking river view condominium spans 5,800 square meters, featuring two elegantly designed residential towers with 789 thoughtfully planned units.

Wake up to panoramic views of the Chao Phraya River and Bangkok’s skyline, framed by minimalist architecture and stylish contemporary interiors. Residents enjoy a curated collection of lifestyle amenities, including a serene infinity pool, fully equipped fitness center, sky lounge, and co-working space—all designed to elevate everyday living.

Whether you’re an international buyer, savvy investor, or urban professional seeking balance, this exceptional riverside address offers both prestige and long-term potential—starting from just THB 4.2 million.

The roadshow will feature private project briefings, one-on-one consultations, and exclusive offers for event attendees. This launch marks a major step in SC Asset’s regional outreach, presenting Bangkok’s rising west riverside zone as the next prime destination for both living and investment.

About SC Asset
SC Asset Corporation Public Company Limited is one of Thailand’s leading real estate developers, known for creating high-quality homes and communities built to last. Guided by the belief that every day should begin with peace of mind, SC Asset is committed to delivering Worry-Free Homes that blend thoughtful design, sustainable innovation, and enduring value.

Alongside residential development, SC Asset continues to expand into hospitality, logistics, and other recurring income businesses to strengthen its balanced, long-term growth. With a clear vision ahead, SC Asset is shaping living experiences that go beyond expectations — with the goal of supporting more than one million residents in worry-free living by 2050. This is why SC Asset remains the trusted foundation for better living, today and tomorrow.

For inquiries or RSVP information:
internationalbuyers@scasset.com |  www.scasset.com
Register to attend: https://forms.gle/enskV2XfNL5N9A558

SNB-101 Earns Government Backing as Promising Therapy for Small Cell Lung Cancer

SEONGNAM, South Korea, July 16, 2025 /PRNewswire/ — In a strong endorsement of its cutting-edge drug delivery technology, SN BioScience announced that its anticancer candidate SNB-101 has been selected as a clinical-stage project under the 2025 Korea Drug Development Project, a government-initiated program led by the Korea Drug Development Fund (KDDF). The program includes two years of research support, aiding the company’s advancement of SNB-101 into global Phase 1b/2 trials.

The Korea Drug Development Fund (KDDF) is a government agency funded by three ministries. It aims to actively fund and provide necessary support for drug development in academia and the pharmaceutical industry.

As Korea’s most authoritative national drug development platform, the KDDF is dedicated to advancing innovative drug development projects, spanning the entire process from early discovery to clinical stages.

SNB-101 is a polymeric nanoparticle-based nanoformulation of SN-38, the potent active metabolite of irinotecan, a topoisomerase I inhibitor in the Camptothecin class. Utilizing its proprietary dual nanomicelle platform, the drug is designed to maximize tumor-specific targeting by leveraging the Enhanced Permeability and Retention (EPR) effect, thereby enhancing therapeutic efficacy while minimizing toxicity to healthy tissues.

SNB-101 has already garnered international recognition through multiple regulatory designations as a next-generation anticancer therapy. The U.S. FDA has granted SNB-101 Orphan Drug Designation for both small cell lung cancer (SCLC) and pancreatic cancer, and has also granted Fast Track Designation for SCLC — a regulatory green light to accelerate its development timeline.

SN BioScience is set to launch a multinational Phase 1b/2 clinical trial for patients with extensive-stage small cell lung cancer (ES-SCLC), spanning key sites across South Korea, the United States, and Europe. The study will focus on dose optimization, safety, and efficacy, with particular emphasis on enrolling a racially and ethnically diverse patient population to support early commercialization efforts.

Given the aggressive nature and poor prognosis of this rare cancer, SNB-101 is gaining attention as a potential second- or third-line treatment for patients who have failed existing therapies. Furthermore, the company is exploring combination strategies with immunotherapies to position SNB-101 as a potential first- or second-line standard of care in the future.

“SNB-101 represents our commitment to overcoming the limitations of conventional cancer therapies,” said Young-Hwan Park, CEO of SN BioScience. “This national grant will accelerate our global clinical development and solidify SNB-101’s position as a next-generation anticancer therapy.”

AUKEY Launches World’s First Qi2.2 Dual-Phone Wireless Charger

LOS ANGELES, July 16, 2025 /PRNewswire/ — Leading wireless charger brand AUKEY today launched its MagFusion 2X 2-in-1 Magnetic Wireless Charger, the brand’s first Qi2.2 charger and among the world’s first.

AUKEY's first Qi2.2 wireless charger — MagFusion 2X
AUKEY’s first Qi2.2 wireless charger — MagFusion 2X

Qi2.2, the Wireless Power Consortium‘s latest charging standard, supports wireless charging up to 25W — a major speed boost compared to Qi2’s 15W. The Qi2.2-certified MagFusion 2X can complete a 0–100% charge 25 minutes faster than Qi2 charging, according to AUKEY’s tests using iPhone 16 Pro Max.

MagFusion 2X’s standout feature is its dual-device design. With the charger’s two built-in Qi2.2 modules, two devices can be charged simultaneously, whether that means two phones, a phone and earbuds, or two users sharing the charger. One device can be charged flat on the charger’s base while a second is charged via a magnetic stand. To allow for a comfortable viewing angle during charging, the stand can be adjusted by 30 degrees.

The charger also showcases AUKEY’s aesthetic strengths, featuring the brand’s signature metallic gray lacquer accented with geometric elements. The result is a modern, streamlined exterior designed to fit in anywhere, from the office to the nightstand.

“As an industry leader, we’re always eager to incorporate cutting-edge technology,” said AUKEY CEO Lu Haichuan. “MagFusion 2X truly reflects the effort our team has poured into it since before the Qi2.2 standard came out. We will be launching a diverse range of Qi2.2 charging products, along with enhancing our existing lineup.”

MagFusion 2X retails at USD$66.99 and comes with a 1.5m cable. Starting today, customers in the US can pre-purchase the product at a 10% early bird discount on AUKEY’s official website (www.AUKEY.com).

Media inquiries can be directed to PR@aukey.com.

About AUKEY

AUKEY is a globally leading provider of cutting-edge consumer electronics designed for both practical and visual appeal. With its user-centric focus, AUKEY’s ever-expanding product line serves as a unique space where technology meets aesthetics.

Meet PETKIT’s Purobot Crystal Duo, the World’s First Open-Top Litter Box That Spots Cat Health Risks Before People Do

Designed for comfort, powered by AI, and built to catch what cats can’t communicate, including early signs of UTIs, this smart litter box brings proactive pet care into the home.

LOS ANGELES, July 16, 2025 /PRNewswire/ — PETKIT proudly announces the pre-launch of Purobot Crystal Duo, the world’s first open-top, AI-powered automatic litter box designed to turn everyday cleanup into a moment of real-time feline health insight. With its cat-friendly open design and intelligent monitoring features, Crystal Duo signals a new era in smart pet care, where hygiene, comfort, and preventative health tracking come together in one seamless solution.

PETKIT PUROBOT Crystal Duo: AI-Powered Open-Top Smart Litter Box for Cat Health Monitoring
PETKIT PUROBOT Crystal Duo: AI-Powered Open-Top Smart Litter Box for Cat Health Monitoring

“An automatic litter box should do more than just clean—it should care,” said J.C. Zhang, Chief Product Designer, “Purobot Crystal Duo was never meant to be a gadget. It’s a health-first product designed to fit naturally into daily life and bring peace of mind to both pets and their people.”

The product’s launch coincides with a broader shift in the pet care landscape. According to the American Pet Products Association (APPA), more pet parents are turning to proactive wellness solutions, especially as cat ownership continues to rise. Crystal Duo not only reflects this trend—it reinforces PETKIT’s position as a category leader in connected pet health innovation.

Smarter Than Scoop-Free. Built for Feline Health.

At the heart of Purobot Crystal Duo is a discreet AI-powered camera that monitors cats’ behavior inside the litter box 24/7. Subtle signs such as loose stool, frequent visits, or excessive yowling may trigger instant alerts through PETKIT app, allowing pet parents to intervene early. When paired with PETKIT’s pH-activated crystal litter, the system can also detect urine pH imbalances, helping identify health risks like urinary tract infections (UTIs) or bladder stones before they escalate.

Expert-Backed Design for Cats and Their Humans

While many automatic litter boxes rely on enclosed designs, research and real-world feedback indicate that many cats tend to avoid covered spaces. As a result, owners are often left frustrated and revert to manual scooping. Purobot Crystal Duo is the first AI litter box to feature an open-top structure, co-developed with veterinarians and feline behaviorists to align with cats’ natural preferences.

The open design encourages comfortable, stress-free use. Dual waste bins enable up to 30 days of hands-free operation, while hygienic, disposable trays make cleaning simple. A built-in N60 odor eliminator keeps the environment fresh and clean all day long.

Vet-Level Insight. Always On. Surprisingly Affordable.

While Purobot Crystal Duo delivers real-time alerts, its deeper value lies in continuous health monitoring. By recognizing subtle changes in routine, it empowers pet parents to act before symptoms become serious—potentially saving on costly vet bills and sparing pets unnecessary pain.

Unlike many tech products that are expensive or complex, Crystal Duo is designed to be both affordable and accessible. It’s not built just for a few. It’s built for every cat parent who wants to care smarter, earlier, and with greater peace of mind.

“Having a pet should bring more joy, not more stress,” said the PETKIT engineering team, “With Crystal Duo, we’re giving cat parents the tools to detect early signs of discomfort before their cat can even show them.”

A Step Forward in Connected Pet Care

While PETKIT has previously introduced AI-powered innovations, Purobot Crystal Duo marks a meaningful leap forward in building a fully connected ecosystem for pet health. As AI capabilities continue to evolve, our goal is to synchronize insights across feeding, hydration, and litter routines—delivering a 360° view of wellbeing through one unified platform.

To us, innovation means nothing without empathy. This open-top design isn’t just a cosmetic change; it reflects a shift toward behavior-driven, health-focused pet care. Crystal Duo answers a real need expressed by cat parents: a solution that supports proactive monitoring, respects feline instincts, and fits naturally into everyday life. We listened, we engineered, and we delivered.

Rooted in technology, guided by care, and centered around the everyday lives of people and pets alike—this is smart pet care made real.

Making Preventative Care Accessible to Every Cat

As proactive care becomes the new standard in pet parenting, PETKIT remains at the forefront of innovation. With the introduction of Crystal Duo, the company expands its AI-powered product ecosystem. It already includes smart feeders, drinking fountains, and litter solutions, all working together to give pet parents a truly holistic view of their cat’s health.

“We started PETKIT with a stray cat, and we’ve never forgotten that every cat deserves better,” said W.K. Guo, founder of PETKIT, “With Purobot Crystal Duo, we’re bringing that vision to life—not just for some cats, but for every home.”

Availability

PETKIT Purobot Crystal Duo is now available for pre-order at www.petkit.com.
Early adopters will receive exclusive launch discounts.

Media Contact:
PR@petkit.com
www.petkit.com

AUTOCRYPT Announces Successful KOSDAQ Listing

SEOUL, South Korea, July 16, 2025 /PRNewswire/ — AUTOCRYPT, a leading global provider of automotive software and cybersecurity solutions, announced its official listing on the KOSDAQ market of the Korean Exchange (KRX) on July 15th, 2025. The listing is expected to enhance AUTOCRYPT’s global visibility, secure growth capital and strengthen trust with global industry leaders.  

Founded in 2019, AUTOCRYPT has rapidly expanded its global footprint, establishing partnerships with 21 leading automotive OEMs. The company provides end-to-end security for both in-vehicle and external communications, and is expanding into adjacent sectors such as agricultural equipment, construction machinery and robotics, in line with the Cyber Resilience Act (CRA), which mandates cybersecurity for all digitally connected products.

A total of KRW 5.41 trillion (approximately USD 3.9 billion) in margin deposits were pledged by retail investors to participate in the initial public offering. Meanwhile 2,403 institutions took part in the demand forecast, resulting in an oversubscription ratio of 995 to 1. The final offering price was set at KRW 22,000 (USD 16), the upper limit of the initial price range.

Seokwoo Lee, Founder and CEO of AUTOCRYPT, expressed appreciation for the strong investor interest, stating “The market’s response reflects confidence in our proprietary technology and long-term vision. We will continue to invest in research and development, while deepening collaboration with global partners.” He added, “As regulatory demands grow and software-defined vehicles (SDVs) become more prevalent, we are expanding our lineup of cybersecurity tools to better support customers navigating the evolving mobility landscape.

In H2 of 2025 the company plans on expanding its global pipeline and solidify its position as a global leader in automotive cybersecurity through the execution of international projects and strategic partnerships.  

About Autocrypt Co., Ltd.
AUTOCRYPT is the leading player in automotive cybersecurity and smart mobility technologies. It specializes in the development and integration of security software and solutions for in-vehicle systems, V2X communications, Plug&Charge, and fleet management, paving the way towards a secure and reliable C-ITS ecosystem in the age of software-defined vehicles. Its comprehensive suite of automotive cybersecurity testing services and platforms includes the award-winning AutoCrypt CSTP, which supports automotive OEMs and suppliers in meeting regulatory standards ilke ISO/SAE 21434, UNECE WP.29 UN R155, as well as other emerging global standards.